Liz Porterfield


Until end March 2017 Elizabeth was the Head of Strategic Planning and Clinical Priorities within Scottish Government Health and Social Directorates. This involved initiation, development and implementation/delivery of a wide range of healthcare policies, including cancer, coronary heart disease and stroke, diabetes, neurological conditions, genetics and rare diseases, armed forces and veterans’ healthcare as well as chronic pain services.

This led to a wide range of published strategic plans for specific services as well as the National Clinical Strategy (February 2016) which is shaping transformation in the context of the Health and Social Care Delivery Plan (December 2016) and the (then) new Cancer Strategy, Beating Cancer: Ambition and Action (March 2016). The Rare Disease Plan (2014) and various other service specific quality and planning policies, e.g. the Major Trauma service ongoing developments, TAVI in Scotland, vascular services quality framework.

Additionally, Elizabeth chaired several national committees, one of which oversaw the delivery and establishment of,robotic assisted surgery for prostate cancer, with robots now in Aberdeen, Edinburgh and Glasgow.

Elizabeth was appointed as a Trustee (Board) member of Genetic Alliance UK (September 2017) and has now been elected as Deputy Chair. Between September 2017 and June 2018 she worked as Transformational Policy Lead in a part time policy adviser role with NHS Greater Glasgow and Clyde Health Board (NHS GGC). This saw the publication of the development and publication of a joint health and social care services whole system plan – Moving Forward Together - looking to the transformational changes required to continue to support the evolution and delivery of services for the GGC population of 2.1 million people. 

Session title

Future-proofing Cancer care in Scotland

Session synopsis